Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT00869284. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00612183. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00854126. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003278. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03985189. IPD Sharing: NO. Countries: 1. Publications: 1.
HD17 for Intermediate Stage Hodgkin Lymphoma
ClinicalTrials.gov study NCT01356680. IPD Sharing: Not stated. Countries: 1. Publications: 5.
PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma
ClinicalTrials.gov study NCT00943423. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma.
ClinicalTrials.gov study NCT02292979. IPD Sharing: NO. Countries: 5. Publications: 2.
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02954406. IPD Sharing: YES. Countries: 2. Publications: 0.
Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00302757. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00002715. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00644371. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00428142. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Participants With Follicular Non-Hodgkin's Lymphoma (MK-3475-174/IMDZ-G142)
ClinicalTrials.gov study NCT02501473. IPD Sharing: YES. Countries: 0. Publications: 1.
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00006125. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Combination of Nivolumab and DHAP in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (Nivo-DHAP)
ClinicalTrials.gov study NCT04091490. IPD Sharing: NO. Countries: 1. Publications: 3.
Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas
ClinicalTrials.gov study NCT03985696. IPD Sharing: NO. Countries: 1. Publications: 0.
Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00336843. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05805943. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00358982. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.